LISA FOX: Open Payments
NPI 1073957593 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$712 in 15 payments from 6 companies in 2025. Trend: 2023 $734 · 2024 $777 · 2025 $712
Food & beverage: $712
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $300 |
| Janssen Biotech, Inc. | 2 | $139 |
| Regeneron Pharmaceuticals, Inc. | 1 | $124 |
| Madrigal Pharmaceuticals | 1 | $87 |
| Hologic Sales and Service, LLC | 2 | $44 |
| Gilead Sciences, Inc. | 1 | $18 |
Products named: TREMFYA, RINVOQ, DUPIXENT, REZDIFFRA, ACESSA PROVU SYSTEM, SKYRIZI, LINZESS, CREON.
Industry payments across IN — which companies pay providers there.
